Drug advertising news from FiercePharma
News
Pfizer, Merck go for indirect ads
The new trend in drug marketing isn't drug marketing at all. New commercials from Pfizer and Sanofi-Aventis, plus what can only be called a "jewelry campaign" from Merck, show that pharma companies Read more...
Drug websites that catch docs' eyes
Which drug websites do docs turn to most? Merck's Januvia and Takeda's Actos--two diabetes meds--head up the top 10 list. Among the rest are Pfizer's Chantix and Merck/Schering-Plough's Vytorin. Read more...
Pfizer-sponsored ads draw fire in Korea
SPOTLIGHT: Pfizer-sponsored ads draw fire in KoreaKorea's medical association is in hot water for letting Pfizer sponsor its anti-smoking campaign because the ads don't disclose the sponsorship. The Read more...
Merck's Gardasil goes to the movies
Seems like a match made in marketing heaven. Merck has been pushing its Gardasil vaccine -- designed to prevent cervical cancer and genital warts by fending off the human papilloma virus -- via ads Read more...
Drugmakers to delay new-drug ads
There's a waiting period for marriage licenses, IPOs, and flood insurance -- and now, drug advertising. Several big drugmakers called on the Congressional carpet for their advertising campaigns now Read more...
Networking site to link cancer docs, pharma
More from the Web-marketing frontier, where portals and blogs are Read more...
Survey: Pharma not a good info source
Remember last month when Merck CEO Dick Clark remarked on Big Pharma's "trust deficit?" Well, here's quantitative evidence of it. A European Commission study found that healthcare professionals
Read more...Zyrtec 'guerilla' flyers spur blog buzz
A new guerilla marketing campaign for over-the-counter Zyrtec proves one thing: If you want attention in the blogosphere, post a few drug ads on telephone poles. They're flyers designed to appear Read more...
Study: Psych drug ads misleading
Ads for psych drugs in medical journals are often misleading, a new study shows. Half the claims made in these ads offered no backup source that could be verified--and of those that were backed up Read more...
Vytorin records created after the fact
Misleading minutes, swearing execs--just another day at the office for Vytorin's critics. Merck and Schering-Plough face new questions about their controversial Enhance trial as a Congressional Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets